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Feasibility Study of Early Oral Intake after  
Gastrectomy for Gastric Carcinoma
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Purpose: Despite the compelling scientific and clinical data supporting the use of early oral nutrition after major gastrointestinal surgery, 
traditional bowel rest and intravenous nutrition for several postoperative days is still being used widely after gastric cancer surgery.
Materials and Methods: A phase II study was carried out to evaluate the feasibility and safety of postoperative early oral intake (water 
intake on postoperative days (POD) 1-2, and soft diet on POD 3) after a gastrectomy. The primary outcome was morbidity within 30 
postoperative days, which was targeted at <25% based on pilot study data. 
Results: The study subjects were 90 males and 42 females with a mean age 61.5 years. One hundred and four (79%) and 28 (21%) 
patients underwent a distal and total gastrectomy, respectively. The postoperative morbidity rate was within the targeted range (15.2%, 
95% CI, 10.0~22.3%), and there was no hospital mortality. Of the 132 patients, 117 (89%) successfully completed a postoperative 
early oral intake regimen without deviation; deviation in 10 (8%) due to gastrointestinal symptoms and in five (4%) due to the manage-
ment of postoperative complications. The mean times to water intake and a soft diet were 1.0±0.2 and 3.2±0.7 days, respectively, 
and the mean hospital stay was 10.0±6.1 days. 
Conclusions: Postoperative early oral intake after a gastrectomy is feasible and safe, and can be adopted as a standard perioperative care 
after a gastrectomy. Nevertheless, further clinical trials will be needed to evaluate the benefits of early oral nutrition after upper gastroin-
testinal surgery. 
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Introduction
postoperative management of patients undergoing gastrointesti-
nal (GI) surgery traditionally involves bowel rest and the avoidance 
of oral intake of fluid or meals until the resolution of postoperative 
ileus. However, compelling scientific and clinical data support the 
use of early enteral nutrition rather than intravenous nutrition and 
bowel rest after major abdominal surgery.(1) Recent randomized 
trials and a meta-analysis have shown the customary withholding 
of oral intake (nil-by-mouth) over the first postoperative days is 
unnecessary and that patients should be allowed food without delay 
after colorectal surgery.(2,3) The benefits of early oral nutrition as 
part of multimodal rehabilitation also have been well documented 
after major gynecologic,(4) urologic,(5) and vascular surgery.(6) 
However, many surgeons still adhere to ‘nil-by-mouth’ during the 
early postoperative period after upper GI surgery and prefer enteral 
tube feeding distal to a new anastomosis for enteral nutritional sup-
port.
The major factors used to justify the traditional practice of oral 
intake restriction after upper GI surgeries are a fear of anastomo-
sis dehiscence and postoperative ileus. However, this rationale of 
restricted oral nutrition is not evidence-based. A systemic review 
of early oral nutrition after upper GI surgery showed that no high 
quality trial has been conducted to address the topic of early oral 
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nutrition after upper GI surgery.(7) On the contrary, some experi-
mental and clinical studies have demonstrated that early enteral 
nutrition may increase wound healing and anastomotic strength in 
intestines and somatic tissues.(2,8)
The lack of comprehensive evidence regarding best clinical 
practice for perioperative care after gastrectomy has led to a lack of 
uniformity of several postoperative routines between countries and 
institutions. According to a survey on postoperative practice after 
gastrectomy in five Northern European countries, the majority of 
centers still adopt conservative nasogastric tube and ‘nil-by-mouth’ 
regimens for several days after gastrectomy.(9) In Japan, the so-
called ‘conventional fixed diet regimen’ which includes the restric-
tion of oral intake for the first 3~4 postoperative days is prevalent 
among institutions.(10) Furthermore, despite the current practice of 
postoperative early oral nutrition after colorectal and gynecologic 
surgery, relatively few studies have evaluated the feasibility and 
safety of early oral intake after gastric surgery. Accordingly, in this 
study, we evaluated the feasibility and safety of perioperative care 
adopting postoperative early oral intake in patients that had under-
gone elective gastrectomy for gastric carcinoma.
Materials and Methods
1. Study design and sample size
This study was designed as a phase 2 trial aimed at evaluating 
the feasibility of early oral intake after gastrectomy. Inclusion cri-
teria were; histologically proven gastric adenocarcinoma, elective 
gastrectomy (distal or total) either via an open or laparoscopic ap-
proach, an age of ＜80 years, adequate organ function, no history 
of preoperative chemotherapy or radiotherapy, and the provision 
of written informed consent. Exclusion criteria were; an operation 
under emergency conditions (e.g., a gastric outlet obstruction per-
foration or bleeding), a severe underlying medical illness, impaired 
renal, hepatic, cardiovascular, or endocrine function, and severe 
malnutrition [body mass index (BMI) ＜15 kg/m
2]. 
The primary endpoint was postoperative morbidity within 30 
postoperative days. Previous clinical trials have reported morbid-
ity rates after gastrectomy for gastric cancer ranging from 10% to 
30%.(11-13) Our preliminary data of postoperative morbidity for 
patients that met the same inclusion and exclusion criteria showed 
an overall morbidity rate of 20% (95% CI, 16~26%). Assuming an 
upper limit of acceptable morbidity for patients managed with early 
oral intake postoperative care regimen of ＜25%, a sample size of 
130 was found to be required for a single-stage phase 2 design, 
80% power, and a significance level of 0.05.
2. Surgical procedure and the perioperative care 
protocol
Distal or total gastrectomy was performed according to tumor 
location, so as to secure a surgical margin of ＞5 cm in advanced 
gastric cancer and of ＞2 cm in early gastric cancer. D2 lymph-
adenectomy as described by the guidelines issued by the Japanese 
Gastric Cancer Association was used as a standard procedure in 
advanced gastric cancer, and limited lymphadenectomy (D1 plus 
beta) was used in early gastric cancer.(14) Laparoscopic surgery 
was indicated for clinically diagnosed T1N0-1 gastric cancer. After 
distal gastrectomy, gastroduodenostomy (Billroth I) or gastroje-
junostomy (Billroth II or Roux-en Y method) was performed for 
reconstruction according to surgeon’s discretion, and Roux-en Y 
esophagojejunostomy was performed after total gastrectomy. All 
reconstruction procedures were performed using a circular or linear 
stapler. An abdominal drain was used in selected cases, again ac-
cording to surgeon’s discretion. 
All patients were managed postoperatively using a standard-
ized clinical pathway. No preoperative bowel preparation was per-
formed (patients were only fasted overnight before surgery) and a 
nasogastric tube was not used perioperatively. Postoperative pain 
was managed by intravenous patient-controlled analgesia (PCA) 
during the first three postoperative days. A second-generation 
cephalosporin was used for prophylaxis before skin incision until 
24 hours postop. Patients started ingesting water on postoperative 
day 1 [postoperative days (POD) 1], and if patient did not develop 
any specific complaints, such as, nausea, vomiting, or abdominal 
discomfort, a soft diet was given (six times a day) to patients from 
POD 3 until hospital discharge. Intravenous fluid was given during 
the first three postoperative days in the form of a fluid restric-
tion regimen (1,400~1,500 ml/day, standard=60 kg, 1,000 kcal). 
No routine pro-motility or anti-emesis agent was used. Gradual 
compression stockings or an intermittent pneumatic compression 
device was used for venous thrombosis prophylaxis in all patients. 
Patients were encouraged to ambulate actively from POD 1. Hos-
pital discharge was targeted on POD 8, and objective discharge cri-
teria were used to make decisions regarding discharge, namely; no 
sign of a postoperative complication, an ability to ambulate without 
assistance, tolerable pain on oral analgesia, able to take more than 
70% of a given meal, and a willingness to go home.Early Oral Intake after Gastrectomy
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3. Outcome measures
The primary outcome was postoperative morbidity, and the 
secondary outcomes were hospital course criteria, such as, compli-
ance with early oral intake, nausea and vomiting, time to soft diet, 
onset of flatus, postoperative mortality, and hospital stay. The fol-
lowing postoperative complications were predefined and prospec-
tively measured; abdominal bleeding, luminal bleeding, abdominal 
infection, pancreatic fistula, pancreatitis, anastomosis leakage, anas-
tomosis stricture, ileus, duodenal stump leakage, and wound infec-
tion. Other complications were recorded as appropriate. Hospital 
mortality was defined as postoperative death for any cause within 
30 postoperative days, or death within the hospitalization period. 
Late complications, such as, dumping, diarrhea, anemia, and quality 
of life issues were not included in this study. 
4. Statistical analyses
Statistical analyses were performed using the chi-square test or 
the independent t-test as appropriate. SPSS ver. 17.0 (SPSS Inc., 
Chicago, IL, USA) was used throughout, and statistical significance 
was accepted for P-value of less than 0.05.
Results
1. Clinicopathological characteristics
Between July 2009 and April 2010, 132 eligible patients with 
a diagnosis of gastric adenocarcinoma and who underwent elec-
tive gastrectomy were enrolled in this study. Table 1 details patient 
demographic and clinicopathological features. There were 90 males 
Table 1. Clinicopathological features
Patients (N=132)
Age (years±SD) 61.5±12.5
Gender 
  Male 90
  Female 42
BMI (kg/m
2±SD) 23.3±3.0
Medical comorbidity
  None 76 (57.6%)
  One 32 (24.2%)
  Two or more 24 (18.2%)
ASA grade
  I 48 (36.4%)
  II 77 (58.3%)
  III 7 (5.3%)
Operation
  Open distal gastrectomy 38 (28.8%)
  Open total gastrectomy 24 (18.2%)
  Laparoscopic distal gastrectomy 66 (50.0%)
  Laparoscopic total gastrectomy 4 (3.0%)
Lymph node dissection
  D1 plus beta 96 (72.7%)
  D2 36 (27.3%)
Reconstruction method
  Billroth I 45 (34.1%)
  Billroth II 42 (31.8%)
  Roux-en Y gastrojejunostomy 16 (12.1%)
  Roux-en Y esophagojejunostomy 29 (22.0%)
Combined organ resection
  Absent 116 (87.9%)
  Present 16 (12.1%)
Operating time (min±SD) 144±36
TNM stage
  Stage I 102 (77.3%)
  Stage II 10 (7.6%)
  Stage III 11 (8.3%)
  Stage IV 9 (6.8%)
SD = standard deviation; BMI = body mass index; ASA = American 
Society of Anesthesiologists.
Table 2. Surgical outcomes
Patients (N=132)
Water intake (POD±SD) 1.0±0.2
Soft diet (POD±SD) 3.2±0.7
Onset of first flatus (POD±SD) 2.6±1.0
Hospital stay (POD±SD) 10.0±6.1
Postoperative morbidity 20 (15.1%)
Surgical complication 19 (14.4%)
  Abdominal infection 8 (6.1%)
  Luminal bleeding 5 (3.8%)
  Abdominal bleeding 2 (1.5%)
  Pancreatic fistula 2 (1.5%)
  Wound 1 (0.8%)
  Anastomosis leakage 1 (0.8%)
Medical complication 3 (2.3%)
  Pneumonia 2 (1.5%)
  Cardiomyopathy 1 (0.8%)
Hospital mortality 0
POD = postoperative days; SD = standard deviation.Jo DH, et al.
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and 42 females of mean age 61.5 years. Fifty-six (42%) had one or 
more preoperative medical illnesses, and 125 (95%) were assessed 
as having American Society of Anesthesiologists (ASA) grade I 
or II. Distal gastrectomy was performed in 104 (79%), and total 
gastrectomy in 28 (21%) patients (70 (53%) laparoscopic surgeries 
were performed). Thirty-six (27%) patients underwent D2 lymph 
node dissection, and 16 (12%) patients underwent combined organ 
resection during operation. Final TNM stages were; stage I in 102 
(77%), stage II in 10 (8%), stage III in 11 (8%), and stage IV in 9 (7%) 
patients, according to 6
th edition of the AJCC TNM classification. 
2. Surgical outcomes
The mean times to water intake and a soft diet were 1.0±0.2 
and 3.2±0.7 days, respectively, and mean time to onset of first 
flatus was 2.6±1.0 days. Of the 132 patients, 100 (81.3%) patients 
were discharged from hospital on POD 8 after fulfilling the dis-
charge criteria, and the mean hospital stay of all patients was 10.0
±6.1 days (Table 2). 
During the postoperative period, 20 patients developed 19 
surgical and 3 medical complications. The overall postoperative 
morbidity rate was 15.2% (95% CI, 10.0~22.3%). Regarding surgi-
cal complications, abdominal infection (n=8) was the most com-
mon, followed by luminal bleeding (n=5). Of the 19 patients with 
a surgical complication, one patient required reoperation due to an 
anastomosis leakage, and two patients with a pancreatic fistula were 
managed by radiologic intervention. The remaining 16 patients 
responded to conservative treatment. No in-hospital mortality oc-
curred. 
3. Adherence to postoperative early oral intake
117 (89%) of the 132 patients successfully started water intake 
on POD 1 and a soft diet on POD 3. Fifteen (11%) patients failed 
to adhere to the postoperative early oral intake schedule. Of these 
15 patients, 5 stopped oral intake due to the management of post-
operative complication (3 luminal bleedings, 1 abdominal infection, 
and 1 anastomosis leakage), and in 10 patients, an oral diet sched-
ule was delayed due to gastrointestinal symptoms, such as, nau-
sea, vomiting, and abdominal discomfort. Of the 10 patients with 
gastrointestinal symptoms, 7 resumed an oral diet on conservative 
treatment and were discharged from hospital on POD 8, but the 
other 3 required nasogastric tube insertion and hospital discharge 
was delayed (Table 3).
4. Factors that may predict early oral intake failure 
after gastrectomy
A total of 15 (11.4%, 95% CI 7.0~17.9%) patients deviated from 
the postoperative early oral intake schedule with respect to water 
intake or soft diet commencement. To identify variables predictive 
of early postoperative oral intake failure, we compared successes 
and failures with respect to age, gender, BMI, comorbidity, ASA 
score, operation type, reconstruction method, combined organ re-
section, operating time, TNM stage, and postoperative morbidity. 
However, no factor was found to be significantly associated with 
deviation from the early oral intake regimen, but postoperative 
morbidity (P=0.053) and TNM stage (P=0.053) showed a tendency 
to be associated with a deviation (Table 4).
Table 3. Hospital courses of the 15 patients who failed to adhere to the postoperative early oral intake schedule
Patient No. Water intake Soft diet Causes of delay Treatment Hospital stay
Patients with GI symptoms (N=10)
  No. 1~5 POD 2 POD 3 GI symptoms Conservative   8 days
  No. 6~7 POD 1 POD 5 GI symptoms Conservative   8 days
  No. 8 POD 1 POD 6 GI symptoms NG-tube insertion 10 days
  No. 9 POD 1 POD 8 GI symptoms NG- tube insertion 16 days
  No. 10 POD 1 POD 7 GI symptoms NG- tube insertion 20 days
Patients with postoperative morbidity (N=5)
  No. 11 POD 3 POD 5 Luminal bleeding Conservative 10 days
  No. 12 POD 2 POD 7 Luminal bleeding Conservative   9 days
  No. 13 POD 2 POD 3 Luminal bleeding Conservative   8 days
  No. 14 POD 1 POD 8 Anastomosis leakage Operation 53 days
  No. 15 POD 2 POD 5 Abdominal infection Intervention 20 days
POD = postoperative days; GI = gastrointestinal; NG = nasogastric.Early Oral Intake after Gastrectomy
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Discussion
Current practice regarding postoperative early oral nutrition has 
been well established for several abdominal surgical procedures.(15) 
Several randomized controlled trials and meta-analysis have shown 
that early oral food intake is both feasible and safe after gastroin-
testinal surgery, and suggested that it may reduce infection-related 
complications and length of hospital stay as compared with the tra-
ditional ‘nil-by-mouth’ approach.(2) Theoretically, the earlier use 
of the enteral route for nutritional support has several advantages 
over bowel rest and intravenous nutrition, as it may activate normal 
digestive reflexes, which have an important impact on gut recovery, 
which is central to overall recovery after gastrointestinal surgery.(16) 
Furthermore, hospital stays can be reduced by shortening the fast-
ing period after surgery. Not only does this provide more physio-
logic and efficient nutrition, but it also minimizes patient discomfort 
and anxiety caused by an enforced fast after surgery. Better protein 
kinetics and preservation of the immune system as compared 
with intravenous nutrition may also contribute to enhanced wound 
healing and resistance to infection.(17,18) Therefore, enteral nutri-
tion should be initiated as soon as possible after major abdominal 
surgery, unless it is contraindicated, and oral intake is preferable to 
enteral tube feeding as a route of enteral nutrition support.(19) 
Despite advances in surgical techniques and perioperative care, 
limited compelling scientific data regarding best clinical practice 
has led to a lack of national or international consensus on standard 
perioperative care after gastric cancer surgery. As for postoperative 
nutritional support, for example, traditional bowel rest and intra-
venous nutrition for several postoperative days is still being widely 
used after gastric surgery.(9) Furthermore, although anastomosis 
safety and postoperative ileus are the main concerns which have 
lead to the careful introduction of dietary schedule after gastrec-
tomy, no high quality trials have provided evidence to support this 
rationale.(7) To the best of our knowledge, this study is the first 
phase 2 clinical trial to evaluate the feasibility and safety of early 
oral intake after gastrectomy. In this study, the primary outcome, 
postoperative morbidity rate, was within the targeted range (15.2%, 
95% CI, 10.0~22.3%), and most patients (89%) were able to tolerate 
the early oral dietary schedule uneventfully. Therefore, our results 
indicate that early oral intake is feasible and safe after gastrectomy, 
as has been shown after other types of gastrointestinal surgery, and 
suggest that it could be adopted as a standard for perioperative care 
after gastric cancer surgery.
The practice of enteral tube feeding after esophagectomy or 
gastrectomy has been extensively documented in the literature.
(20,21) However, studies on the safety and feasibility of early 
oral intake after gastric surgery are limited. Suehiro et al.(22) first 
reported accelerated rehabilitation with postoperative early oral 
intake in patients undergoing gastrectomy. In their study, surgical 
outcomes after gastrectomy of an early oral intake group (liquid 
Table 4. Analysis of factors associated with deviation from the 
postoperative early oral intake schedule
Variables
Deviation
(N=15)
Success
(N=117)
P-
value
Age (years) 61.6±12.5 61.1±12.9 0.889
BMI (kg/m
2±SD) 23.4±3.0 22.7±3.2 0.423
Operating time (min±SD) 144±36 145±38 0.934
Gender 0.894
  Male 10 (11.1%) 80 (88.9%)
  Female   5 (11.9%) 37 (88.1%)
ASA score 0.378
  I   7 (14.6%) 41 (85.4%)
  II or III 8 (9.5%) 76 (90.5%)
Comorbidity 0.190
  Absent 11 (14.5%) 65 (85.5%)
  Present 4 (7.1%) 52 (92.9%)
Resection type 0.310
  Distal 10 (9.6%) 94 (90.4%)
  Total   5 (17.8%) 23 (82.2%)
Operative approach 0.312
  Open   9 (14.3%) 54 (85.7%)
  Laparoscopic 6 (8.7%) 63 (91.3%)
Reconstruction 0.128
  BI 3 (6.7%) 42 (93.3%)
  BII 3 (7.1%) 39 (92.9%)
  RYGJ   4 (23.5%) 13 (76.5%)
  RYEJ   5 (17.8%) 23 (82.2%)
Combined organ resection 0.693
  Absent 14 (12.1%) 102 (87.9%)
  Present 1 (6.3%) 15 (93.7%)
Postoperative morbidity 0.053
  Absent 10 (8.9%) 102 (91.1%)
  Present   5 (27.8%) 15 (72.2%)
TNM stage 0.053
  Stage I/II 10 (8.9%) 102 (91.1%)
  Stage III/IV   5 (27.8%) 15 (72.2%)
RYGJ = Roux-en Y gastrojejunostomy; RYEJ= Roux-en Y esophago-
jejunostomy.Jo DH, et al.
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diet within 48 hrs) and a traditional group (‘nil-by-mouth’ until 
resolution of postoperative ileus) were retrospectively reviewed, 
and it was found that postoperative recovery was better in the early 
oral intake group, as indicated by earlier onset of flatus, and shorter 
fasting period and hospital stays. In a subsequent non-randomized 
comparative study conducted by Hirao et al.(10) a so called ‘pa-
tient-controlled dietary schedule’ (water intake on POD 1, liquid 
diet on POD 2, and solid diet on demand) was compared with a 
conventional diet regimen (postoperative nil-by-mouth) in patients 
that had undergone distal gastrectomy. Like Suehiro et al.(22), they 
found that early oral intake after gastrectomy was feasible and that 
it caused no increase in postoperative morbidity. A large multicenter 
randomized trial conducted by Lassen and colleagues compared a 
routine of allowing normal food at will from POD 1 with a nil-by-
mouth/enteral tube feeding routine for 5 days after upper gastroin-
testinal surgery. They concluded that the early institution of an oral 
diet probably enhances postoperative recovery, as indicated by time 
to first flatus and shorter hospital stay, and that it has no adverse 
effect on major morbidities.(23) However, only 36% of the patients 
enrolled underwent gastric surgery, and thus, further clinical trials 
are needed for each type of surgery to determine best postoperative 
practice. Recently, Hur et al.(24) reported the results of a small pilot 
study on early oral intake after gastrectomy, which showed bet-
ter postoperative recovery and no increased risk of gastrointestinal 
complications. 
The early resumption of oral nutrition could probably be en-
hanced by adopting multimodal approaches to improve gastroin-
testinal recovery and reduce postoperative surgical stress. Postop-
erative nausea and vomiting and transient ileus are predominantly 
neural and inflammatory responses to abdominal surgery, and may 
markedly delay the early resumption of oral nutrition. However, 
during past decades, substantial advances have been made in our 
understanding of surgical stress response and postoperative recov-
ery.(15) For example, as demonstrated by our standardized periop-
erative care procedure, preoperative bowel preparation, routine use 
of an abdominal drain, and nasogastric tube insertion are no longer 
considered indispensible for patients undergoing elective gastrec-
tomy.(25) Intravenous fluid infusion restriction may also enhance 
bowel recovery and reduce postoperative complications,(26) and the 
use of epidural analgesia, short acting intraoperative opioids, and 
effective antiemetic agents may promote the success of early oral 
nutrition after surgery.(27) Recently, these multimodal strategies, 
also known as ‘fast-track surgery’, have been extensively investi-
gated in the contexts of colonic, gynecologic, and upper abdominal 
laparoscopic procedures.(15) However, reports regarding gastric 
surgery are scarce, and study is required to evaluate the benefits of 
these multimodal strategies in gastric cancer patients. 
The extent of resection or type of operative approach might 
influence on the feasibility of early oral intake after gastric surgery. 
However, in this study, no significant variables including patient 
and operation-related factors were found to predict a failure of 
postoperative early oral intake regimen. Theoretically, total gastrec-
tomy is presumed to be less tolerable to early oral intake than distal 
gastrectomy due to no gastric reservoir after surgery. Laparoscopic 
surgery is also believed to contribute to enhancing postoperative 
bowel recovery as compared with open surgery.(28) Despites not 
reaching statistical significance, 17.8% of patients with total gas-
trectomy failed to adhere to early oral dietary schedule, compared 
to 9.6% in patients with distal gastrectomy. Laparoscopic surgery 
also showed lower failure rate than open surgery (8.7% vs. 14.3% 
in open surgery). Considering relatively small size of this study, we 
think these factors should be further evaluated in large clinical trials 
for establishing proper indication of early oral intake perioperative 
care after gastric cancer surgery. 
In the colcusion, this study shows that a perioperative care pro-
gram incorporating the early institution of oral intake is feasible 
and safe after gastrectomy. Furthermore, early oral intake was not 
found to increase postoperative morbidity, and was tolerated by 
most patients without any adverse event. Accordingly, we suggest 
that early oral feeding could be adopted as a standardized periop-
erative care procedure after gastrectomy. Finally, further clinical 
trials are warranted to evaluate the benefits of early oral feeding on 
postoperative recovery, reducing postoperative complications, and 
on immunologic and nutritional functions. 
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